 |
|
|
| |
Assessment of Safety and Efficacy of Abacavir/Lamivudine and Tenofovir/Emtricitabine in Treatment-Naïve HIV-1 Infected Subjects
ASSERT: 48-Week Result
|
| |
| |
Reported by Jules Levin
EACS November 13 2009, Cologne, Germany
HJ Stellbrink, G Moyle, C Orkin, J Arribas, H Pearce, P Zucchi for the ASSERT Team
Study Sponsored by GSK
|
| |
|
|
|
|
|
